Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C13H16N2O4 |
| Molecular Weight | 264.2771 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC(=O)CC[C@H](NC(=O)CC1=CC=CC=C1)C(O)=O
InChI
InChIKey=JFLIEFSWGNOPJJ-JTQLQIEISA-N
InChI=1S/C13H16N2O4/c14-11(16)7-6-10(13(18)19)15-12(17)8-9-4-2-1-3-5-9/h1-5,10H,6-8H2,(H2,14,16)(H,15,17)(H,18,19)/t10-/m0/s1
| Molecular Formula | C13H16N2O4 |
| Molecular Weight | 264.2771 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:53:51 UTC 2023
by
admin
on
Fri Dec 15 17:53:51 UTC 2023
|
| Record UNII |
92358I79RG
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
189804
Created by
admin on Fri Dec 15 17:53:51 UTC 2023 , Edited by admin on Fri Dec 15 17:53:51 UTC 2023
|
||
|
FDA ORPHAN DRUG |
267408
Created by
admin on Fri Dec 15 17:53:51 UTC 2023 , Edited by admin on Fri Dec 15 17:53:51 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
17884
Created by
admin on Fri Dec 15 17:53:51 UTC 2023 , Edited by admin on Fri Dec 15 17:53:51 UTC 2023
|
PRIMARY | |||
|
C1613
Created by
admin on Fri Dec 15 17:53:51 UTC 2023 , Edited by admin on Fri Dec 15 17:53:51 UTC 2023
|
NO STRUCTURE GIVEN | |||
|
8087
Created by
admin on Fri Dec 15 17:53:51 UTC 2023 , Edited by admin on Fri Dec 15 17:53:51 UTC 2023
|
PRIMARY | |||
|
92358I79RG
Created by
admin on Fri Dec 15 17:53:51 UTC 2023 , Edited by admin on Fri Dec 15 17:53:51 UTC 2023
|
PRIMARY | |||
|
203800
Created by
admin on Fri Dec 15 17:53:51 UTC 2023 , Edited by admin on Fri Dec 15 17:53:51 UTC 2023
|
PRIMARY | |||
|
DTXSID90182324
Created by
admin on Fri Dec 15 17:53:51 UTC 2023 , Edited by admin on Fri Dec 15 17:53:51 UTC 2023
|
PRIMARY | |||
|
m11916
Created by
admin on Fri Dec 15 17:53:51 UTC 2023 , Edited by admin on Fri Dec 15 17:53:51 UTC 2023
|
PRIMARY | |||
|
PHENYLACETYLGLUTAMINE
Created by
admin on Fri Dec 15 17:53:51 UTC 2023 , Edited by admin on Fri Dec 15 17:53:51 UTC 2023
|
PRIMARY | |||
|
28047-15-6
Created by
admin on Fri Dec 15 17:53:51 UTC 2023 , Edited by admin on Fri Dec 15 17:53:51 UTC 2023
|
PRIMARY | |||
|
92258
Created by
admin on Fri Dec 15 17:53:51 UTC 2023 , Edited by admin on Fri Dec 15 17:53:51 UTC 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE |
Formed in the liver and excreted in the urine responsible for the reduction of ammonia in the blood.
MAJOR
URINE
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
